- 1、本文档共2页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Hotline: 400-820-3792
Inhibitors • Screening Libraries • Proteins
www.MedChemE
Hsp90-Cdc37-IN-3
Cat. No.: HY-144650
CAS No.: 2361009-68-7
分⼦式: C₃₅H₄₄ClN₃O₆
分⼦量: 638.19
作⽤靶点: Apoptosis; HSP
作⽤通路: Apoptosis; Cell Cycle/DNA Damage; Metabolic
Enzyme/Protease
储存⽅式: Please store the product under the recommended conditions in
the Certificate of Analysis.
BIOLOGICAL ACTIVITY
⽣物活性 Hsp90-Cdc37-IN-3 (Compound 9) 是⼀种具有抗癌活性 (anticancer) 的新型 celastrol−imidazole 衍⽣物。
Hsp90-Cdc37-IN-3 通过共价结合抑制 Hsp90−Cdc37,诱导细胞凋亡 (apoptosis) [1]。
IC50 Target Hsp90-Cdc37
体外研究 Hsp90-Cdc37-IN-3 (Compound 9) (24 h) shows broad-spectrum antitumor potential with IC50 values of 0.54,
0.59, 0.57, and 0.57 µM against A549, HTC116, U2OS, and MDA-MB231 cells, respectively [1].
Hsp90-Cdc37-IN-3 (0-5 µM, 12 h) inhibits Hsp90−Cdc37 and influences the function of apoptosis-related
proteins by covalently combining with both Hsp90 and Cdc37 [1].
Hsp90-Cdc37-IN-3 (0-0.8 µM, 48 h) induces apoptosis significantly in A549 cells [1].
Hsp90-Cdc37-IN-3 (0-0.4 µM, 24 h) arrests the cell cycle in the G0/G1 phase in a dose-dependent manner
[1].
Western Blot Analysis [1]
Cell Line: A549
您可能关注的文档
- HBV-IN-19-DataSheet-生命科学试剂-MedChemExpress.pdf
- HBV-IN-19-TFA-DataSheet-生命科学试剂-MedChemExpress.pdf
- HDAC6-IN-7-DataSheet-生命科学试剂-MedChemExpress.pdf
- HDAC-IN-35-DataSheet-生命科学试剂-MedChemExpress.pdf
- hENT4-IN-1-DataSheet-生命科学试剂-MedChemExpress.pdf
- HER2-IN-7-DataSheet-生命科学试剂-MedChemExpress.pdf
- HER2-IN-8-DataSheet-生命科学试剂-MedChemExpress.pdf
- Hit-1-DataSheet-生命科学试剂-MedChemExpress.pdf
- HIV-1-inhibitor-19-DataSheet-生命科学试剂-MedChemExpress.pdf
- HIV-1-inhibitor-20-DataSheet-生命科学试剂-MedChemExpress.pdf
文档评论(0)